03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Forxiga 5mg* : | |
Type | Medicine Non Marketed |
Originator | B |
Agent | Omnipharma |
Distributor | Omnipharma |
Laboratory | AstraZeneca |
Responsible Party | Bristol Myers Squibb/ AstraZeneca EEIG |
Origin | UK |
Manufacturer | Bristol-Myers Squibb SRL |
Origin | Italy |
ATC | A10BK01 |
Forxiga 5mg* :
Forxiga 5mg* :
Forxiga 5mg* :
Forxiga 5mg* :
Forxiga 5mg* :
Hazard Level |
---|
◼ Major |
◼ Moderate |
◼ Minor |
◼ Safe |
Forxiga 5mg* :
Forxiga 5mg* :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Back pain | Common |
Balanitis candida | Common |
Balanoposthitis | Common |
Blood creatinine increased | Uncommon |
Blood parathyroid hormone increased | Not known |
Blood urea increased | Uncommon |
Constipation | Uncommon |
Creatinine renal clearance decreased | Common |
Cystitis | Common |
Dehydration | Uncommon |
Dizziness | Common |
Dry mouth (Xerostomia) | Uncommon |
Dyslipidaemia | Common |
Dysuria (Micturition painful) | Common |
Escherichia urinary tract infection | Common |
Fungal infection | Uncommon |
Genital candidiasis | Common |
Genital infection | Common |
Genital infection fungal | Common |
Genital infection male (Male reproductive tract infections) | Common |
Genitourinary tract infection | Common |
Glomerular filtration rate decreased | Not known |
Haematocrit increased | Common |
Hypoglycaemia | Very Common |
Hypotension | Uncommon |
Hypovolaemia (Volume depletion) (Hypovolemia) | Uncommon |
Kidney infection | Common |
Nocturia | Uncommon |
Penile infection | Common |
Pollakiuria (Urinary frequency) | Common |
Polyuria | Common |
Prostatitis | Common |
Pruritus genital | Uncommon |
Pyelonephritis | Common |
Renal failure | Not known |
Renal impairment | Uncommon |
Thirst | Uncommon |
Trigonitis | Common |
Urethritis | Common |
Urinary tract infection | Common |
Urine output increased | Common |
Vaginal infection | Common |
Vaginitis bacterial | Common |
Vulval abscess | Common |
Vulvitis | Common |
Vulvovaginal candidiasis | Common |
Vulvovaginal mycotic infection | Common |
Vulvovaginal pruritus | Uncommon |
Vulvovaginitis | Common |
Weight decreased (Weight loss) | Uncommon |
Forxiga 5mg* :
NB : Products With Same Indication |
Different Units By MoH Code
Forxiga 5mg* MoH 7885 :
Form | Tablet, Film-Coated |
Packaging | Blisters (Al/Al) |
Package Size | Box of 28 |
Strength | 5mg |
Storage Condition | <30°C None |
NSSF | ✘ |
Quarantine | ✘ |
Reg. Number | 87014/1 |
Submission date | 01/01/2014 |
Registration Year | 2015 |
Archived Date | 2017 |
Price Comparison
● Country: | Denmark | |
● Package Size: | 28 | |
● Public Price: | 498.4 DKK | ( 6,467,238.40 LBP ) |
● Pack size unit used: | 28 | |
● Cost/Unit: | 17,8 DKK | ( 220,592.00 LBP ) |
● Pharmacy Price: | 365.48 DKK | ( 4742468.48 LBP ) |
● Reference: | Danish Medicine Agency | |
● Pricing Date: | 19/05/2021 | |
● Type: | Medicine Authorised |
● Country: | Abu Dhabi | |
● Package Size: | 28 | |
● Public Price: | 259.5 AED | ( 6,269,779.50 LBP ) |
● Pack size unit used: | 28 | |
● Cost/Unit: | 9,2679 AED | ( 217,449.00 LBP ) |
● Pharmacy Price: | 208.92 AED | ( 5047716.12 LBP ) |
● Pricing Date: | 27/01/2021 | |
● Type: | Medicine Authorised |
● Country: | UAE | |
● Package Size: | 28's (14's Blister x 2) | |
● Public Price: | 259.5 AED | ( 6,269,779.50 LBP ) |
● Pack size unit used: | 28 | |
● Cost/Unit: | 9,2679 AED | ( 217,449.00 LBP ) |
● Pharmacy Price: | 208.92 AED | ( 5047716.12 LBP ) |
● Pricing Date: | 21/08/2019 | |
● Type: | Medicine Authorised |
● Country: | Switzerland | |
● Package Size: | 28 | |
● Public Price: | 64.75 CHF | ( 6,696,445.00 LBP ) |
● Pack size unit used: | 28 | |
● Cost/Unit: | 2,3125 CHF | ( 206,840.00 LBP ) |
● Exfactory Price: | 42.12 CHF | |
● Pricing Date: | 04/04/2021 | |
● Type: | Medicine Authorised |
● Country: | Iceland | |
● Package Size: | 28stk | |
● Public Price: | 8444 ISK | ( 5,446,380.00 LBP ) |
● Pack size unit used: | 28 | |
● Cost/Unit: | 301,5714 ISK | ( 194,145.00 LBP ) |
● Pharmacy Price: | 5073 ISK | ( 3272085 LBP ) |
● Reference: | Icelandic Medicines Agency | |
● Pricing Date: | 01/04/2020 | |
● Type: | Medicine Authorised |
● Country: | Finland | |
● Package Size: | 28 | |
● Public Price: | 63.6 EUR | ( 6,161,313.60 LBP ) |
● Pack size unit used: | 28 | |
● Cost/Unit: | 2,2714 EUR | ( 193,752.00 LBP ) |
● Reference: | Kela | |
● Pricing Date: | 22/04/2021 | |
● Type: | Medicine Authorised |
● Country: | Qatar | |
● Package Size: | 28 | |
● Public Price: | 178 QAR | ( 4,371,324.00 LBP ) |
● Pack size unit used: | 28 | |
● Cost/Unit: | 6,3571 QAR | ( 147,348.00 LBP ) |
● Pharmacy Price: | 146.000509382 QAR | ( 3585480.5094032 LBP ) |
● Pricing Date: | 28/01/2021 | |
● Type: | Medicine Authorised |
● Country: | Sweden | |
● Package Size: | 28 | |
● Public Price: | 421.63 SEK | ( 3,545,065.04 LBP ) |
● Pack size unit used: | 28 | |
● Cost/Unit: | 15,0582 SEK | ( 126,120.00 LBP ) |
● Pharmacy Price: | 368.02 SEK | ( 3094312.16 LBP ) |
● Pricing Date: | 23/04/2020 | |
● Type: | Medicine Authorised |
● Country: | KSA | |
● Package Size: | 28 | |
● Public Price: | 159 SAR | ( 3,758,760.00 LBP ) |
● Pack size unit used: | 28 | |
● Cost/Unit: | 5,6786 SAR | ( 118,200.00 LBP ) |
● Reference: | sfda | |
● Pricing Date: | 16/01/2021 | |
● Type: | Medicine Authorised |
● Country: | UK | |
● Package Size: | 28 | |
● Public Price: | 36.59 GBP | ( 4,158,416.91 LBP ) |
● Pack size unit used: | 28 | |
● Cost/Unit: | 1,3068 GBP | ( 113,649.00 LBP ) |
● Reference: | DMD | |
● Pricing Date: | 08/03/2021 | |
● Type: | Medicine Authorised |
● Country: | Norway | |
● Package Size: | 28 | |
● Public Price: | 398 NOK | ( 3,225,392.00 LBP ) |
● Pack size unit used: | 28 | |
● Cost/Unit: | 14,2143 NOK | ( 113,456.00 LBP ) |
● Pharmacy Price: | 283.72 NOK | ( 2299266.88 LBP ) |
● Reference: | Norwegian Medicine Agency | |
● Pricing Date: | 01/04/2020 | |
● Type: | Medicine Authorised |
● Country: | Belgium | |
● Package Size: | 28 | |
● Public Price: | 47 EUR | ( 4,553,172.00 LBP ) |
● Pack size unit used: | 28 | |
● Cost/Unit: | 1,6786 EUR | ( 96,876.00 LBP ) |
● Reference: | cbip | |
● Pricing Date: | 27/11/2020 | |
● Type: | Medicine Authorised |
● Country: | Greece | |
● Package Size: | 28 | |
● Public Price: | 48.75 EUR | ( 4,722,705.00 LBP ) |
● Pack size unit used: | 28 | |
● Cost/Unit: | 1,7411 EUR | ( 96,876.00 LBP ) |
● Exfactory Price: | 33.73 EUR | |
● Pharmacy Price: | 35.38 EUR | ( 3427472.88 LBP ) |
● Reference: | National Organization for Medicines | |
● Pricing Date: | 25/02/2021 | |
● Type: | Medicine Authorised |
● Country: | Ireland | |
● Package Size: | 28 | |
● Public Price: | 41.27 EUR | ( 3,998,072.52 LBP ) |
● Pack size unit used: | 28 | |
● Cost/Unit: | 1,4739 EUR | ( 96,876.00 LBP ) |
● Exfactory Price: | 39 EUR | |
● Pricing Date: | 09/10/2020 | |
● Type: | Medicine Authorised |
● Country: | Bahrain | |
● Package Size: | 28 | |
● Public Price: | 17.06 BHD | ( 4,055,742.04 LBP ) |
● Pack size unit used: | 28 | |
● Cost/Unit: | 0,6093 BHD | ( 0.00 LBP ) |
● Reference: | nhra | |
● Pricing Date: | 09/02/2021 | |
● Type: | Medicine Authorised |
● Country: | Oman | |
● Package Size: | 28 | |
● Public Price: | 18.71 OMR | ( 4,317,033.14 LBP ) |
● Pack size unit used: | 28 | |
● Cost/Unit: | 0,6682 OMR | ( 0.00 LBP ) |
● Pricing Date: | 19/02/2021 | |
● Type: | Medicine Authorised |
● Country: | Kuweit | |
● Package Size: | 28 | |
● Public Price: | 14.58 KWD | ( 4,280,410.98 LBP ) |
● Pack size unit used: | 28 | |
● Cost/Unit: | 0,5207 KWD | ( 0.00 LBP ) |
● Pharmacy Price: | 12.31 KWD | ( 3613982.11 LBP ) |
● Pricing Date: | 07/02/2021 | |
● Type: | Medicine Authorised |
Note
You have to register to view this info
Drop File